Casitas B-lineage lymphoma b inhibits antigen recognition and slows cell cycle progression at late times during CD4+ T cell clonal expansion

Journal of Immunology

Volumn 181, Issue 8, 2008, Pages 5331-5339

  Zhang, Ruan ^a   Zhang, Na ^a   Mueller, Daniel L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD71 ANTIGEN; PHOSPHOLIPASE C GAMMA1; PROTEIN KINASE B; TOLL LIKE RECEPTOR; ANTIGEN; CBL PROTEIN; CBLB PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C GAMMA; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CELL CYCLE PROGRESSION; CELL DIVISION; CELL GROWTH; CELL LINEAGE; CONTROLLED STUDY; DEREGULATION; HEREDITY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION; ANIMAL; CD4+ T LYMPHOCYTE; CELL CYCLE; GENETICS; IMMUNOLOGY; MOUSE MUTANT; PHOSPHORYLATION; TIME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MICE; MICE, KNOCKOUT; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTORS, ANTIGEN, T-CELL; TIME FACTORS;

EID: 54049108861     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.8.5331     Document Type: Article

References (39)

1. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184: 747-752. (Pubitemid 26324129)
2. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388: 782-787. (Pubitemid 27375158)
3. Iezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8: 89-95. (Pubitemid 28097826)
4. + T cell response. J. Exp. Med. 201: 1555-1565.
5. Obst, R., H. M. van Santen, R. Melamed, A. O. Kamphorst, C. Benoist, and D. Mathis. 2007. Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation. Proc. Natl. Acad. Sci. USA 104: 15460-15465.
6. + T cell activation. Immunity 27: 625-634.
7. + T cells undergo immediate growth arrest upon cessation of TCR signaling in vivo. J. Immunol. 180: 156-162.
8. Smith, A. L., M. E. Wikstrom, and B. Fazekas de St. Groth. 2000. Visualizing T cell competition for peptide/MHC complexes: a specific mechanism to minimize the effect of precursor frequency. Immunity 13: 783-794.
9. + T cell survival controlled by clonal abundance. Science 312: 114-116.
10. Yokoi, N., K. Komeda, H. Y. Wang, H. Yano, K. Kitada, Y. Saitoh, Y. Seino, K. Yasuda, T. Serikawa, and S. Seino. 2002. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat. Genet. 31: 391-394.
11. Chiang, Y. J., H. K. Kole, K. Brown, M. Naramura, S. Fukuhara, R. J. Hu, I. K. Jang, J. S. Gutkind, E. Shevach, and H. Gu. 2000. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403: 216-220.
12. Bachmaier, K., C. Krawczyk, I. Kozieradzki, Y. Y. Kong, T. Sasaki, A. Oliveira-dos-Santos, S. Mariathasan, D. Bouchard, A. Wakeham, A. Itie, et al. 2000. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403: 211-216. (Pubitemid 30050966)
13. Qiao, G., Z. Li, L. Molinero, M. L. Alegre, H. Ying, Z. Sun, J. M. Penninger, and J. Zhang. 2008. T-cell receptor-induced NF-κB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. Mol. Cell. Biol. 28: 2470-2480.
14. Fang, D., and Y. C. Liu. 2001. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat. Immunol. 2: 870-875. (Pubitemid 34906453)
15. Fang, D., H. Y. Wang, N. Fang, Y. Altman, C. Elly, and Y. C. Liu. 2001. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells. J. Biol. Chem. 276: 4872-4878.
16. Heissmeyer, V., F. Macian, S. H. Im, R. Varma, S. Feske, K. Venuprasad, H. Gu, Y. C. Liu, M. L. Dustin, and A. Rao. 2004. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat. Immunol. 5: 255-265. (Pubitemid 38332122)
17. Jeon, M. S., A. Atfield, K. Venuprasad, C. Krawczyk, R. Sarao, C. Elly, C. Yang, S. Arya, K. Bachmaier, L. Su, et al. 2004. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21: 167-177.
18. Safford, M., S. Collins, M. A. Lutz, A. Allen, C. T. Huang, J. Kowalski, A. Blackford, M. R. Horton, C. Drake, R. H. Schwartz, and J. D. Powell. 2005. Egr-2 and Egr-3 are negative regulators of T cell activation. Nat. Immunol. 6: 472-480. (Pubitemid 41716760)
19. Kaye, J., and S. M. Hedrick. 1988. Analysis of specificity for antigen, Mls, and allogenic MHC by transfer of T-cell receptor α- and β-chain genes. Nature 336: 580-583. (Pubitemid 19007316)
20. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84: 1374-1378. (Pubitemid 17027356)
21. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356: 607-609.
22. Bonnevier, J. L., C. A. Yarke, and D. L. Mueller. 2006. Sustained B7/CD28 interactions and resultant phosphatidylinositol 3-kinase activity maintain G(1)->S phase transitions at an optimal rate. Eur. J. Immunol. 36: 1583-1597.
23. Vanasek, T. L., A. Khoruts, T. Zell, and D. L. Mueller. 2001. Antagonistic roles for CTLA-4 and the mammalian target of rapamycin in the regulation of clonal anergy: enhanced cell cycle progression promotes recall antigen responsiveness. J. Immunol. 167: 5636-5644.
24. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171: 131-137. (Pubitemid 24140219)
25. Zheng, Y., S. L. Collins, M. A. Lutz, A. N. Allen, T. P. Kole, P. E. Zarek, and J. D. Powell. 2007. A role for mammalian target of rapamycin in regulating T cell activation versus anergy. J. Immunol. 178: 2163-2170. (Pubitemid 46233414)
26. Zhang, J., T. Bardos, D. Li, I. Gal, C. Vermes, J. Xu, K. Mikecz, A. Finnegan, S. Lipkowitz, and T. T. Glant. 2002. Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination. J. Immunol. 169: 2236-2240. (Pubitemid 34920962)
27. Garcia, Z., E. Pradelli, S. Celli, H. Beuneu, A. Simon, and P. Bousso. 2007. Competition for antigen determines the stability of T cell-dendritic cell interactions during clonal expansion. Proc. Natl. Acad. Sci. USA 104: 4553-4558. (Pubitemid 47186263)
28. Ruben, S., H. Poteat, T. H. Tan, K. Kawakami, R. Roeder, W. Haseltine, and C. A. Rosen. 1988. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product. Science 241: 89-92. (Pubitemid 18168122)
29. Lopez-Cabrera, M., E. Munoz, M. V. Blazquez, M. A. Ursa, A. G. Santis, and F. Sanchez-Madrid. 1995. Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-α-responsive elements. J. Biol. Chem. 270: 21545-21551.
30. Bonnevier, J. L., and D. L. Mueller. 2002. Cutting edge: B7/CD28 interactions regulate cell cycle progression independent of the strength of TCR signaling. J. Immunol. 169: 6659-6663.
31. Song, J., S. Salek-Ardakani, T. So, and M. Croft. 2007. The kinases aurora B and mTOR regulate the G1-S cell cycle progression of T lymphocytes. Nat. Immunol. 8: 64-73. (Pubitemid 46242360)
32. Song, J., T. So, M. Cheng, X. Tang, and M. Croft. 2005. Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 22: 621-631. (Pubitemid 40719197)
33. Shamim, M., S. G. Nanjappa, A. Singh, E. H. Plisch, S. E. LeBlanc, J. Walent, J. Svaren, C. Seroogy, and M. Suresh. 2007. Cbl-b regulates antigen-induced TCR down-regulation and IFN-γ production by effector CD8 T cells without affecting functional avidity. J. Immunol. 179: 7233-7243.
34. Mercado, R., S. Vijh, S. E. Allen, K. Kerksiek, I. M. Pilip, and E. G. Pamer. 2000. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165: 6833-6839. (Pubitemid 32001151)
35. + T lymphocyte responses. Nat. Immunol. 4: 361-365.
36. Brennan, P., J. W. Babbage, B. M. Burgering, B. Groner, K. Reif, and D. A. Cantrell. 1997. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7: 679-689. (Pubitemid 28156635)
37. Colombetti, S., V. Basso, D. L. Mueller, and A. Mondino. 2006. Prolonged TCR/ CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin. J. Immunol. 176: 2730-2738. (Pubitemid 43306931)
38. Colombetti, S., F. Benigni, V. Basso, and A. Mondino. 2002. Clonal anergy is maintained independently of T cell proliferation. J. Immunol. 169: 6178-6186.
39. Khoruts, A., A. Mondino, K. A. Pape, S. L. Reiner, and M. K. Jenkins. 1998. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J. Exp. Med. 187: 225-236. (Pubitemid 28060438)